Wuhan Keqian Biology Co Ltd (688526) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Wuhan Keqian Biology Co Ltd (688526) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥174.36 Million ≈ $25.51 Million USD) by net assets (CN¥4.17 Billion ≈ $610.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Wuhan Keqian Biology Co Ltd worth for the company's overall valuation and market capitalisation.

Wuhan Keqian Biology Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Wuhan Keqian Biology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Wuhan Keqian Biology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Keqian Biology Co Ltd ranked by their cash flow conversion efficiency. Explore Wuhan Keqian Biology Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Nuveen Select Tax-Free Income Portfolio NYSE:NXP	-0.002x
Neuca S.A. WAR:NEU	0.133x
AB SKF (publ) ST:SKF-A	0.034x
FARO Technologies Inc NASDAQ:FARO	0.019x
Santacruz Silver Mining Ltd. V:SCZ	0.072x
Wetown Electric Group Co Ltd SHG:688226	0.008x
Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret A.S. IS:EUPWR	-0.023x
Daewoong Pharma KO:069620	0.057x

Annual Cash Flow Conversion Efficiency for Wuhan Keqian Biology Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Wuhan Keqian Biology Co Ltd from 2016 to 2024. View 688526 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.94 Billion ≈ $576.99 Million	CN¥392.68 Million ≈ $57.46 Million	0.100x	-28.97%
2023-12-31	CN¥3.84 Billion ≈ $561.57 Million	CN¥538.03 Million ≈ $78.73 Million	0.140x	+15.78%
2022-12-31	CN¥3.50 Billion ≈ $512.02 Million	CN¥423.71 Million ≈ $62.00 Million	0.121x	-28.11%
2021-12-31	CN¥3.15 Billion ≈ $461.52 Million	CN¥531.27 Million ≈ $77.74 Million	0.168x	+14.02%
2020-12-31	CN¥2.71 Billion ≈ $396.34 Million	CN¥400.14 Million ≈ $58.55 Million	0.148x	+6.73%
2019-12-31	CN¥1.12 Billion ≈ $163.74 Million	CN¥154.89 Million ≈ $22.67 Million	0.138x	-65.52%
2018-12-31	CN¥876.34 Million ≈ $128.24 Million	CN¥351.83 Million ≈ $51.48 Million	0.401x	-19.92%
2017-12-31	CN¥673.41 Million ≈ $98.54 Million	CN¥337.61 Million ≈ $49.40 Million	0.501x	-6.16%
2016-12-31	CN¥413.10 Million ≈ $60.45 Million	CN¥220.69 Million ≈ $32.29 Million	0.534x	--

About Wuhan Keqian Biology Co Ltd

SHG:688526 China Biotechnology

Market Cap

$849.20 Million

CN¥5.80 Billion CNY

Market Cap Rank

#9765 Global

#2550 in China

Share Price

CN¥12.45

Change (1 day)

-0.32%

52-Week Range

CN¥11.84 - CN¥17.86

All Time High

CN¥47.40